1. Home
  2. WBX vs SGMO Comparison

WBX vs SGMO Comparison

Compare WBX & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • SGMO
  • Stock Information
  • Founded
  • WBX 2015
  • SGMO 1995
  • Country
  • WBX Spain
  • SGMO United States
  • Employees
  • WBX N/A
  • SGMO N/A
  • Industry
  • WBX Industrial Specialties
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WBX Consumer Discretionary
  • SGMO Health Care
  • Exchange
  • WBX Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • WBX 102.7M
  • SGMO 122.8M
  • IPO Year
  • WBX N/A
  • SGMO 2000
  • Fundamental
  • Price
  • WBX $6.00
  • SGMO $0.53
  • Analyst Decision
  • WBX Buy
  • SGMO Buy
  • Analyst Count
  • WBX 3
  • SGMO 6
  • Target Price
  • WBX $0.72
  • SGMO $4.50
  • AVG Volume (30 Days)
  • WBX 26.4K
  • SGMO 5.9M
  • Earning Date
  • WBX 07-31-2025
  • SGMO 08-05-2025
  • Dividend Yield
  • WBX N/A
  • SGMO N/A
  • EPS Growth
  • WBX N/A
  • SGMO N/A
  • EPS
  • WBX N/A
  • SGMO N/A
  • Revenue
  • WBX $171,352,140.00
  • SGMO $63,756,000.00
  • Revenue This Year
  • WBX N/A
  • SGMO N/A
  • Revenue Next Year
  • WBX $44.10
  • SGMO N/A
  • P/E Ratio
  • WBX N/A
  • SGMO N/A
  • Revenue Growth
  • WBX 3.75
  • SGMO 239.92
  • 52 Week Low
  • WBX $4.60
  • SGMO $0.30
  • 52 Week High
  • WBX $32.80
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • WBX 36.26
  • SGMO 49.93
  • Support Level
  • WBX $6.10
  • SGMO $0.50
  • Resistance Level
  • WBX $6.36
  • SGMO $0.61
  • Average True Range (ATR)
  • WBX 0.67
  • SGMO 0.05
  • MACD
  • WBX -0.06
  • SGMO 0.01
  • Stochastic Oscillator
  • WBX 42.41
  • SGMO 58.45

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: